TY - JOUR AU - Ceylanoglu, K.S. AU - Eisenberg, A. AU - Worden, F.P. AU - Elner, V.M. AU - Demirci, H. TI - Use of Cemiplimab, an Immune Checkpoint Inhibitor for Conjunctival Intraepithelial Neoplasia JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 4 SP - 528 EP - 530 PG - 3 SN - 0277-3740 DO - 10.1097/ICO.0000000000003452 UR - https://m2.mtmt.hu/api/publication/34780026 ID - 34780026 N1 - Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, United States University of Michigan, Ann Arbor, MI, United States Division of Medical Oncology, University of Michigan, Ann Arbor, MI, United States Export Date: 9 April 2024 CODEN: CORND Correspondence Address: Demirci, H.; Department of Ophthalmology and Visual Sciences, 1000 Wall St, United States; email: hdemirci@med.umich.edu LA - English DB - MTMT ER - TY - JOUR AU - Martínez-Plaza, E. AU - Molina-Martín, A. AU - Piñero, D.P. TI - Reliability and Agreement of Keratometry Measurements Obtained With Eye Surface Profilometry and Partial Coherence Interferometry JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 3 SP - 343 EP - 348 PG - 6 SN - 0277-3740 DO - 10.1097/ICO.0000000000003348 UR - https://m2.mtmt.hu/api/publication/34735463 ID - 34735463 N1 - Export Date: 13 March 2024 CODEN: CORND Correspondence Address: Piñero, D.P.; Group of Optics and Visual Perception, Spain; email: david.pinyero@ua.es LA - English DB - MTMT ER - TY - JOUR AU - Atik, Burcu Kemer AU - Emul, Merve AU - Kirgiz, Ahmet AU - Cubuk, Mehmet Ozgur AU - Ahmet, Sibel AU - Besek, Nilay Kandemir TI - Effect of Keratoconus Stage and Classification Parameters on Deep Anterior Lamellar Keratoplasty Outcomes JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 3 SP - 327 EP - 332 PG - 6 SN - 0277-3740 DO - 10.1097/ICO.0000000000003362 UR - https://m2.mtmt.hu/api/publication/34645509 ID - 34645509 LA - English DB - MTMT ER - TY - JOUR AU - Price, Marianne O. AU - Price, David A. AU - Price Jr, Francis W. TI - Long-Term Risk of Steroid-Induced Ocular Hypertension/Glaucoma With Topical Prednisolone Acetate 1% After Descemet Stripping Endothelial Keratoplasty JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 3 SP - 323 EP - 326 PG - 4 SN - 0277-3740 DO - 10.1097/ICO.0000000000003312 UR - https://m2.mtmt.hu/api/publication/34645497 ID - 34645497 LA - English DB - MTMT ER - TY - JOUR AU - Caputo, Roberto AU - Di Grande, Laura AU - de Libero, Cinzia AU - Marziali, Elisa AU - Mori, Francesca AU - Masini, Marzio TI - Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 2 SP - 228 EP - 232 PG - 5 SN - 0277-3740 DO - 10.1097/ICO.0000000000003368 UR - https://m2.mtmt.hu/api/publication/34644861 ID - 34644861 LA - English DB - MTMT ER - TY - JOUR AU - Arboleda, Alejandro AU - Prajna, N. Venkatesh AU - Lalitha, Prajna AU - Srinivasan, Muthiah AU - Rajaraman, Revathi AU - Krishnan, Tiruvengada AU - Mousa, Hazem M. AU - Feghali, James AU - Acharya, Nisha R. AU - Lietman, Thomas M. AU - Perez, Victor L. AU - Rose-Nussbaumer, Jennifer TI - Validation of the C-DU(KE) Calculator as a Predictor of Outcomes in Patients Enrolled in Steroids for Corneal Ulcer and Mycotic Ulcer Treatment Trials JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 2 SP - 166 EP - 171 PG - 6 SN - 0277-3740 DO - 10.1097/ICO.0000000000003313 UR - https://m2.mtmt.hu/api/publication/34626226 ID - 34626226 LA - English DB - MTMT ER - TY - JOUR AU - Marolo, P. AU - Ribero, S. AU - Caselgrandi, P. AU - Ghilardi, A. AU - De, Sanctis U. AU - Parisi, G. AU - Fallico, M. AU - Borrelli, E. AU - Ortoncelli, M. AU - Gelato, F. AU - Mastorino, L. AU - Tibaldi, T. AU - Roccuzzo, G. AU - Quaglino, P. AU - Reibaldi, M. TI - Ocular Surface Disease in Patients with Atopic Dermatitis Treated with Dupilumab: A Prospective Case-Control Study JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 2 SP - 221 EP - 227 PG - 7 SN - 0277-3740 DO - 10.1097/ICO.0000000000003341 UR - https://m2.mtmt.hu/api/publication/34514765 ID - 34514765 N1 - Department of Ophthalmology, University of Turin, Turin, Italy Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy Department of Ophthalmology, University of Catania, Catania, Italy Vita-Salute San Raffaele University, Milan, Italy Cited By :1 Export Date: 18 January 2024 CODEN: CORND Correspondence Address: Marolo, P.; Department of Ophthalmology, Via Cherasco 23, Italy; email: paola@marolo.com Chemicals/CAS: dupilumab, 1190264-60-8; Antibodies, Monoclonal, Humanized; dupilumab AB - Purpose:The aim of this study was to evaluate the variation of dry eye disease (DED) prevalence in patients with atopic dermatitis (AD) treated with dupilumab.Methods:This prospective case-control study included consecutive patients with moderate-to-severe AD scheduled for dupilumab between May and December 2021 and healthy subjects. DED prevalence, the Ocular Surface Disease Index, tear film breakup time test, osmolarity, Oxford staining score, and Schirmer test results were collected at baseline, 1 month, and 6 months after dupilumab therapy. The Eczema Area and Severity Index was assessed at baseline. Ocular side effects and discontinuation of dupilumab were also recorded.Results:Seventy-two eyes from 36 patients with AD treated with dupilumab and 36 healthy controls were included. Prevalence of DED increased from 16.7% at baseline to 33.3% at 6 months in the dupilumab group (P = 0.001), whereas it remained unchanged in the control group (P = 0.110). At 6 months, the Ocular Surface Disease Index and Oxford score increased (from 8.5 ± 9.8 to 11.0 ± 13.0, P = 0.068, and from 0.1 ± 0.5 to 0.3 ± 0.6, P = 0.050, respectively), the tear film breakup time test and Schirmer test results decreased (from 7.8 ± 2.6 s to 7.1 ± 2.7 s, P < 0.001, and from 15.4 ± 9.6 mm to 13.2 ± 7.9 mm, P = 0.036, respectively) in the dupilumab group, whereas they remained stable in the control group (P > 0.05). Osmolarity was unchanged (dupilumab P = 0.987 and controls P = 0.073). At 6 months after dupilumab therapy, 42% of patients had conjunctivitis, 36% blepharitis, and 2.8% keratitis. No severe side effects were reported, and none of the patients discontinued dupilumab. No association between Eczema Area and Severity Index and DED prevalence was shown.Conclusions:DED prevalence increased in patients with AD treated with dupilumab at 6 months. However, no severe ocular side effects were found and no patient discontinued therapy. © 2024 Lippincott Williams and Wilkins. All rights reserved. LA - English DB - MTMT ER - TY - JOUR AU - Vernin, Alice AU - Schrittenlocher, Silvia AU - Matthaei, Mario AU - Roters, Sigrid AU - Siebelmann, Sebastian AU - Bachmann, Bjoern AU - Schiller, Petra AU - Cursiefen, Claus AU - Schlereth, Simona L. TI - Excimer Laser Phototherapeutic Keratectomy for Anterior Corneal Opacification After Descemet Membrane Endothelial Keratoplasty JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 1 SP - 95 EP - 104 PG - 10 SN - 0277-3740 DO - 10.1097/ICO.0000000000003396 UR - https://m2.mtmt.hu/api/publication/34665452 ID - 34665452 LA - English DB - MTMT ER - TY - JOUR AU - Moreno-Martinez, Almudena AU - Martin-Melero, Oscar AU - Andres-Pretel, Fernando AU - Gomez-Cortes, Alfonso AU - Granados-Centeno, Jose M. TI - Outcomes of Phacoemulsification With Toric Intraocular Lenses in Addressing Postkeratoplasty Astigmatism JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 1 SP - 76 EP - 82 PG - 7 SN - 0277-3740 DO - 10.1097/ICO.0000000000003288 UR - https://m2.mtmt.hu/api/publication/34645502 ID - 34645502 LA - English DB - MTMT ER - TY - JOUR AU - Borgia, A. AU - Coco, G. AU - Airaldi, M. AU - Romano, D. AU - Pagano, L. AU - Semeraro, F. AU - Menassa, N. AU - Gadhvi, K.A. AU - Kaye, S.B. AU - Romano, V. TI - Role of Direct Supervision in the Learning Curve of Descemet Membrane Endothelial Keratoplasty Surgery JF - CORNEA J2 - CORNEA VL - 43 PY - 2024 IS - 1 SP - 52 EP - 58 PG - 7 SN - 0277-3740 DO - 10.1097/ICO.0000000000003278 UR - https://m2.mtmt.hu/api/publication/34448921 ID - 34448921 N1 - Eye Unit, Humanitas-Gradenigo Hospital, Turin, Italy Department of Corneal Diseases, St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom Department of Clinical Science and Translational Medicine, University of Rome Tor Vergata, Rome, Italy Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Ophthalmology Clinic, University of Brescia, Italy Eye Unit, University Hospitals of Leicester, NHS Trust, Leicester, United Kingdom Department of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom Export Date: 22 December 2023 CODEN: CORND Correspondence Address: Coco, G.; Department of Clinical Science and Translational Medicine, Viale Oxford 81, Italy; email: giulia.coco@uniroma2.it AB - Purpose:The aim of this study was to compare complication rates of Descemet membrane endothelial keratoplasty (DMEK) performed by directly supervised and nondirectly supervised corneal fellows.Methods:This study was a retrospective, comparative case series of DMEK surgeries performed by novice surgeons (less than 15 DMEK cases) with or without direct direct expert supervision. Patients who underwent surgery for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy with a minimum follow-up of 12 weeks were included. Data on patients' demographics, surgical details, surgeon level, intraoperative and postoperative complications, and rate of rebubbling were collected.Results:In this study, 41 nondirectly supervised and 48 directly supervised DMEK surgeries were included. At 6 months, 67.4% of eyes achieved a best-corrected visual acuity of & le;0.3 logMAR with no significant difference between groups (P = 0.95). Intraoperative complications occurred in 22% of cases in the nondirect supervision group and 4.2% in the direct supervision group (P = 0.02). Postoperative complications occurred in 9.8% of cases in the nondirect supervision group and 6.2% of cases in the direct supervision group (P = 0.7). The rebubbling rate was comparable in the 2 groups (34.1% vs. 33.3%, P = 1.0). Five cases (12.2%), all from the nondirect supervision group, required secondary keratoplasty (P = 0.02). The overall complication rate was significantly higher in the nondirect supervision group (31.7% vs. 10.4%, P = 0.03).Conclusions:Functional success can be achieved in directly supervised or nondirectly supervised DMEK surgery. However, nondirectly supervised DMEK surgery may associate with higher rates of complications. © 2024 Lippincott Williams and Wilkins. All rights reserved. LA - English DB - MTMT ER -